Methotrexate Patent Expiration
Methotrexate is Used for treating conditions such as cancer, rheumatoid arthritis, and certain types of psoriasis. It was first introduced by Otter Pharmaceuticals Llc
Methotrexate Patents
Given below is the list of patents protecting Methotrexate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Jylamvo | US11129833 | Methotrexate formulation | Oct 28, 2035 | Shorla |
| Jylamvo | US11771701 | Methotrexate formulation | Oct 29, 2034 | Shorla |
| Otrexup | US8814834 | Injector safety device | May 27, 2031 | Otter Pharms |
| Otrexup | US11497753 | Hazardous agent injection system | Mar 19, 2030 | Otter Pharms |
| Otrexup | US8480631 | Hazardous agent injection system | Mar 19, 2030 | Otter Pharms |
| Otrexup | US8579865 | Hazardous agent injection system | Mar 19, 2030 | Otter Pharms |
| Otrexup | US8945063 | Hazardous agent injection system | Mar 19, 2030 | Otter Pharms |
| Otrexup | US9421333 | Hazardous agent injection system | Mar 19, 2030 | Otter Pharms |
| Rasuvo | US8664231 | Concentrated methotrexate solutions | Jun 01, 2029 | Medexus |
| Otrexup | US10709844 | Injector safety device | Mar 10, 2029 | Otter Pharms |
| Otrexup | US11684723 | Injector safety device | Mar 10, 2029 | Otter Pharms |
| Otrexup | US9867949 | Injector safety device | Mar 10, 2029 | Otter Pharms |
| Otrexup | US8021335 | Prefilled syringe jet injector | Oct 04, 2026 | Otter Pharms |
| Otrexup | US11446441 | Prefilled syringe injector | Jan 24, 2026 | Otter Pharms |
| Otrexup | US8562564 | Prefilled syringe jet injector | Jan 24, 2026 | Otter Pharms |
| Otrexup | US9533102 | Prefilled syringe jet injector | Jan 24, 2026 | Otter Pharms |
| Otrexup | US9629959 | Prefilled syringe jet injector | Jan 24, 2026 | Otter Pharms |
| Otrexup | US6746429 | Needle assisted jet injector |
Apr 12, 2020
(Expired) | Otter Pharms |
| Otrexup | US7744582 | Needle assisted jet injector |
Aug 10, 2019
(Expired) | Otter Pharms |
| Otrexup | US7776015 | Needle assisted jet injector |
Aug 10, 2019
(Expired) | Otter Pharms |
| Otrexup | USRE44846 | Needle assisted jet injector |
Aug 10, 2019
(Expired) | Otter Pharms |
| Otrexup | USRE44847 | Needle assisted jet injector |
Aug 10, 2019
(Expired) | Otter Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Methotrexate's patents.
Latest Legal Activities on Methotrexate's Patents
Given below is the list recent legal activities going on the following patents of Methotrexate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Aug, 2021 | US8664231(Litigated) |
| Review Certificate Mailed | 03 Sep, 2019 | US8664231(Litigated) |
| Review Certificate | 13 Aug, 2019 | US8664231(Litigated) |
| Termination or Final Written Decision | 07 Feb, 2018 | US8664231(Litigated) |
| Request for Trial Granted Critical | 08 Feb, 2017 | US8664231(Litigated) |
| Termination or Final Written Decision | 08 Dec, 2016 | US8664231(Litigated) |
| Request for Trial Granted in Part | 01 Sep, 2016 | US8664231(Litigated) |
| Petition Requesting Trial | 20 Jul, 2016 | US8664231(Litigated) |
| Petition Requesting Trial | 22 Feb, 2016 | US8664231(Litigated) |
| Termination or Final Written Decision | 30 Apr, 2015 | US8664231(Litigated) |
Methotrexate's Family Patents
